USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Angstrom Medica, Inc.
Address:
Angstrom Medica, Inc.
150 -A New Boston St
Woburn, MA 01801
Phone:
(781) 933-6121
URL:
N/A
EIN:
43565545
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $361,595.00 3
SBIR Phase II $499,999.00 1
STTR Phase I $390,360.00 2

Award List:

SBIR Phase I: Manufacturing and Testing of Nanocrystalline Hydroxyapatite Orthopedic Implants

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
NSF
Principal Investigator:
Edward Ahn
Abstract:
This Small Business Innovation Research (SBIR)Phase I project proposes to develop forming and sintering processes suitable for the manufacture of nanocrystalline hydroxyapatite orthopedic implants. Though hydroxyapatite's osteoconductivity has generated interest in many clinical applications,… More

SBIR Phase I: Scalable Synthesis and Processing of Nanocrystalline Hydroxyapatite

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
NSF
Principal Investigator:
Edward Ahn
Abstract:
This Small Business Innovation Research Phase I project will develop processes and controls for producing commercial quantities of nanostructured hydroxyapatite (HAP) biomaterials suitable for load bearing orthopedic and dental applications. Though hydroxyapatite's … More

SBIR Phase II: Scalable Synthesis and Processing of Nanocrystalline Hydroxyapatite

Award Year / Program / Phase:
2004 / SBIR / Phase II
Award Amount:
$499,999.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research Phase II Project proposes to use a newly developed synthetic nanocrystalline hydroxyapatite (HAP) bone material to produce high-strength, resorbable synthetic bone implants for anterior cruciate ligament surgeries. This material solves the problem of current… More

Nano-Ceramic for Metabolic Stem Cell Engineering

Award Year / Program / Phase:
2004 / STTR / Phase I
Award Amount:
$99,822.00
Agency:
HHS
Principal Investigator:
Research Institution:
TUFTS UNIVERSITY BOSTON
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): The overall objective of this project is to develop a clinically and commercially viable tissue engineered bone construct using nanocrystalline ceramic scaffolds for proliferating and differentiating adipose-derived progenitor cells into cells of the osteogenic… More

Tricalcium Phosphate for Orthopedic Applications

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$161,595.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Titanium and resorbable polymers are the materials of choice when reattaching the ACL with an interference screw. While titanium screws possess sufficient strength to withstand insertion and the holding power to retain the ACL in the bone, tearing of the ACL and… More

Novel Nanostructured Calcium Phosphate for Gene Delivery to Bone

Award Year / Program / Phase:
2005 / STTR / Phase I
Award Amount:
$290,538.00
Agency:
HHS
Principal Investigator:
Research Institution:
BRIGHAM & WOMEN'S HOSPITAL
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): Osteoporosis is a major and growing health care problem that responds inadequately to standard pharmacologic therapy. Because of its low bone mineral density, osteoporotic bone is mechanically weak and fractures more easily than normal bone. Moreover, fracture… More